Statin, inflammation, and sepsis [3] (multiple letters)

Chest

Volumn 125, Issue 6, 2004, Pages 2365-

  Inoue, Ken Ichiro ^a   Takano, Hirohisa ^a   Yanagisawa, Rie ^a   Sakurai, Miho ^a   Yoshikawa, Toshikazu ^a   Almog, Yaniv ^b,c  

^a NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c Ben Gurion University ^*  (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; ANTIINFLAMMATORY AGENT; CYTOKINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOMODULATING AGENT; INTERLEUKIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;

ANTIINFLAMMATORY ACTIVITY; COLITIS; DRUG EFFECT; IMMUNOMODULATION; INFLAMMATORY DISEASE; LETTER; LUNG INJURY; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RHEUMATOID ARTHRITIS; SEPSIS;

EID: 2942755656     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.6.2365     Document Type: Letter

References (9)

1. Y. Almog Statins, inflammation, and sepsis: hypothesis Chest 124 2003 740 743
2. F Mulhaupt CM Matter BR Kwak Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells Cardiovasc Res 59 2003 755 766
3. I Zelvyte R Dominaitiene M Crisby Modulation of inflammatory mediators and PPAR and NFPPB expression by pravastatin in response to lipoproteins in human monocytes in vitro. Pharmacol Res 45 2002 147 154
4. I Inoue F Itoh S Aoyagi Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFPPB Biochem Biophys Res Commun 290 2002 131 139
5. CG Su X Wen ST Bailey A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response J Clin Invest 104 1999 383 389
6. Y Kawahito M Kondo Y Tsubouchi 15-deoxy-delta-(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats J Clin Invest 106 2000 189 197
7. A Diab C Deng JD Smith Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis J Immunol 168 2002 2508 2515
8. R Thieringer JE Fenyk-Melody CB Le Grand Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-α responses of macrophages to lipopolysaccharide in vitro or in vivo. J Immunol 164 2000 1046 1054
9. K Inoue H Takano R Yanagisawa Effect of 15-deoxy-D12,14-prostaglandin J2 on acute lung in jury induced by lipopolysaccharide in mice Eur J Pharmacol 481 2003 261 269